149 related articles for article (PubMed ID: 9010229)
1. The PDGF receptor phosphorylates Tyr 138 in the c-Src SH3 domain in vivo reducing peptide ligand binding.
Broome MA; Hunter T
Oncogene; 1997 Jan; 14(1):17-34. PubMed ID: 9010229
[TBL] [Abstract][Full Text] [Related]
2. Molecular interactions of the Src homology 2 domain protein Shb with phosphotyrosine residues, tyrosine kinase receptors and Src homology 3 domain proteins.
Karlsson T; Songyang Z; Landgren E; Lavergne C; Di Fiore PP; Anafi M; Pawson T; Cantley LC; Claesson-Welsh L; Welsh M
Oncogene; 1995 Apr; 10(8):1475-83. PubMed ID: 7537362
[TBL] [Abstract][Full Text] [Related]
3. Association of Fyn with the activated platelet-derived growth factor receptor: requirements for binding and phosphorylation.
Twamley GM; Kypta RM; Hall B; Courtneidge SA
Oncogene; 1992 Oct; 7(10):1893-901. PubMed ID: 1408131
[TBL] [Abstract][Full Text] [Related]
4. Crk protein binds to PDGF receptor and insulin receptor substrate-1 with different modulating effects on PDGF- and insulin-dependent signaling pathways.
Sorokin A; Reed E; Nnkemere N; Dulin NO; Schlessinger J
Oncogene; 1998 May; 16(19):2425-34. PubMed ID: 9627109
[TBL] [Abstract][Full Text] [Related]
5. STAT activation by the PDGF receptor requires juxtamembrane phosphorylation sites but not Src tyrosine kinase activation.
Sachsenmaier C; Sadowski HB; Cooper JA
Oncogene; 1999 Jun; 18(24):3583-92. PubMed ID: 10380880
[TBL] [Abstract][Full Text] [Related]
6. Identification of Tyr-762 in the platelet-derived growth factor alpha-receptor as the binding site for Crk proteins.
Yokote K; Hellman U; Ekman S; Saito Y; Rönnstrand L; Saito Y; Heldin CH; Mori S
Oncogene; 1998 Mar; 16(10):1229-39. PubMed ID: 9546424
[TBL] [Abstract][Full Text] [Related]
7. PDGF-induced phosphorylation of Tyr28 in the N-terminus of Fyn affects Fyn activation.
Hansen K; Alonso G; Courtneidge SA; Rönnstrand L; Heldin CH
Biochem Biophys Res Commun; 1997 Dec; 241(2):355-62. PubMed ID: 9425276
[TBL] [Abstract][Full Text] [Related]
8. RACK1: a novel substrate for the Src protein-tyrosine kinase.
Chang BY; Harte RA; Cartwright CA
Oncogene; 2002 Oct; 21(50):7619-29. PubMed ID: 12400005
[TBL] [Abstract][Full Text] [Related]
9. Receptor association and tyrosine phosphorylation of S6 kinases.
Rebholz H; Panasyuk G; Fenton T; Nemazanyy I; Valovka T; Flajolet M; Ronnstrand L; Stephens L; West A; Gout IT
FEBS J; 2006 May; 273(9):2023-36. PubMed ID: 16640565
[TBL] [Abstract][Full Text] [Related]
10. Regulation of the cellular src protein tyrosine kinase: interactions of the carboxyl terminal sequences residing between the kinase domain and tyrosine-527.
Cobb BS; Parsons JT
Oncogene; 1993 Nov; 8(11):2897-903. PubMed ID: 7692368
[TBL] [Abstract][Full Text] [Related]
11. Activation of the Src-family tyrosine kinase Hck by SH3 domain displacement.
Moarefi I; LaFevre-Bernt M; Sicheri F; Huse M; Lee CH; Kuriyan J; Miller WT
Nature; 1997 Feb; 385(6617):650-3. PubMed ID: 9024665
[TBL] [Abstract][Full Text] [Related]
12. Requirement for c-Src catalytic activity and the SH3 domain in platelet-derived growth factor BB and epidermal growth factor mitogenic signaling.
Broome MA; Hunter T
J Biol Chem; 1996 Jul; 271(28):16798-806. PubMed ID: 8663329
[TBL] [Abstract][Full Text] [Related]
13. Activation of Stat3 preassembled with platelet-derived growth factor beta receptors requires Src kinase activity.
Wang YZ; Wharton W; Garcia R; Kraker A; Jove R; Pledger WJ
Oncogene; 2000 Apr; 19(17):2075-85. PubMed ID: 10815799
[TBL] [Abstract][Full Text] [Related]
14. Regulation of c-Src tyrosine kinase activity by the Src SH2 domain.
Liu X; Brodeur SR; Gish G; Songyang Z; Cantley LC; Laudano AP; Pawson T
Oncogene; 1993 May; 8(5):1119-26. PubMed ID: 7683128
[TBL] [Abstract][Full Text] [Related]
15. Domain interactions in protein tyrosine kinase Csk.
Sondhi D; Cole PA
Biochemistry; 1999 Aug; 38(34):11147-55. PubMed ID: 10460171
[TBL] [Abstract][Full Text] [Related]
16. Sequence requirements for binding of Src family tyrosine kinases to activated growth factor receptors.
Alonso G; Koegl M; Mazurenko N; Courtneidge SA
J Biol Chem; 1995 Apr; 270(17):9840-8. PubMed ID: 7730365
[TBL] [Abstract][Full Text] [Related]
17. Mutation of a Src phosphorylation site in the PDGF beta-receptor leads to increased PDGF-stimulated chemotaxis but decreased mitogenesis.
Hansen K; Johnell M; Siegbahn A; Rorsman C; Engström U; Wernstedt C; Heldin CH; Rönnstrand L
EMBO J; 1996 Oct; 15(19):5299-313. PubMed ID: 8895575
[TBL] [Abstract][Full Text] [Related]
18. Two signaling molecules share a phosphotyrosine-containing binding site in the platelet-derived growth factor receptor.
Nishimura R; Li W; Kashishian A; Mondino A; Zhou M; Cooper J; Schlessinger J
Mol Cell Biol; 1993 Nov; 13(11):6889-96. PubMed ID: 7692233
[TBL] [Abstract][Full Text] [Related]
19. Direct interaction between Shc and the platelet-derived growth factor beta-receptor.
Yokote K; Mori S; Hansen K; McGlade J; Pawson T; Heldin CH; Claesson-Welsh L
J Biol Chem; 1994 May; 269(21):15337-43. PubMed ID: 8195171
[TBL] [Abstract][Full Text] [Related]
20. Phosphotyrosine binding domain-dependent upregulation of the platelet-derived growth factor receptor alpha signaling cascade by transforming mutants of Cbl: implications for Cbl's function and oncogenicity.
Bonita DP; Miyake S; Lupher ML; Langdon WY; Band H
Mol Cell Biol; 1997 Aug; 17(8):4597-610. PubMed ID: 9234717
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
